» Articles » PMID: 18952418

A Facile Synthesis, Antibacterial, and Antitubercular Studies of Some Piperidin-4-one and Tetrahydropyridine Derivatives

Overview
Specialty Biochemistry
Date 2008 Oct 28
PMID 18952418
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The raise in clinical significance of multidrug-resistant bacterial pathogens has directed us to synthesize 2,6-diarylpiperidin-4-one and Delta(3)-tetrahydropyridin-4-ol based benzimidazole and O-arylsulfonyl derivatives. X-ray crystal structure of tetrahydropyridinol (23) confirmed a change in conformation and orientation of substituents upon amide formation. Antibacterial activities evaluated against a wide number of bacterial pathogens (both sensitive and multidrug-resistant) revealed that 19, 27 against Staphylococcus aureus, 27 against Enterococcus faecalis, and 19, 21, 23, and 27 against Enterococcus faecium are significantly good at lowest MIC(90) (16 microg/mL). Inhibitory power noticed by 23 against Vancomycin-Linezolid-resistant E. faecalis and 27 against Vancomycin-resistant E. faecium are onefold better than the standard Linezolid and Trovafloxacin drugs, respectively. Moreover, antitubercular activity for the selected compounds against Mycobacterium tuberculosis H37Rv revealed that compounds 23, 24, and 27 expressed onefold improved potency compared to the standard Rifampicin drug.

Citing Articles

Cervicovaginal microbiota isolated from healthy women exhibit probiotic properties and antimicrobial activity against pathogens isolated from cervical cancer patients.

Kamble A, Naik S, Talathi M, Jadhav D, Pingale S, Kaul-Ghanekar R Arch Microbiol. 2022; 204(8):491.

PMID: 35840844 DOI: 10.1007/s00203-022-03103-5.


Design, docking, and DFT investigations of 2,6-bis(3,4-dihydroxyphenyl)-3-phenethylpiperidin-4-one.

Sasitha T, John W Heliyon. 2021; 7(2):e06127.

PMID: 33659730 PMC: 7890216. DOI: 10.1016/j.heliyon.2021.e06127.


Identification of a 3,3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2.

Bi W, Xiao J, Liu R, Zhou L, Zhang S, Yang M Invest New Drugs. 2019; 38(2):287-298.

PMID: 31076964 DOI: 10.1007/s10637-019-00792-6.


Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.

Revathi R, Venkatesha Perumal R, Pai K, Arunkumar G, Sriram D, Kini S Drug Des Devel Ther. 2015; 9:3779-87.

PMID: 26229439 PMC: 4516184. DOI: 10.2147/DDDT.S83047.


Crystal structure of 4-chloro-N-[2-(piperidin-1-yl)eth-yl]benzamide monohydrate.

Prathebha K, Jonathan D, Revathi B, Sathya S, Usha G Acta Crystallogr E Crystallogr Commun. 2015; 71(Pt 1):o39-40.

PMID: 25705496 PMC: 4331843. DOI: 10.1107/S2056989014026851.